Condition: Ulcerative Colitis · Crohn's Disease · Sponsor: AbbVie
Crohn's disease (CD) is an incurable chronic inflammatory disorder of the gastrointestinal tract. Ulcerative colitis (UC) is an idiopathic, chronic, inflammatory disease affecting the colon. This study will assess the (long-term) effectiveness and safety of upadacitinib in real-world clinical practice in adult participants with moderate to severe ulcerative colitis (UC) and crohn's disease (CD). Upadacitinib is an approved drug for treating ulcerative colitis (UC) and Crohn's disease (CD). Approximately 280 participants who are prescribed Upadacitinib by their physician in accordance with local label will be enrolled in 8 sites across Belgium. Participants will receive upadacitinib as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 3 years. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice
This description comes directly from the study's public registry record.
Liesbeth Ghys · 844-663-3742 · liesbeth.ghys@abbvie.com
Always discuss trial participation with your own doctor first.
| Imelda Ziekenhuis /ID# 268631 | Bonheiden, Antwerpen, Belgium | Recruiting |
| Universite Libre de Bruxelles - Hopital Erasme /ID# 268632 | Anderlecht, Brussels Capital, Belgium | Recruiting |
| CHU de Liège /ID# 267209 | Liège, Liege, Belgium | Recruiting |
| UZ Gent /ID# 268630 | Ghent, Oost-Vlaanderen, Belgium | Recruiting |
| Vitaz /Id# 268637 | Sint-Niklaas, Oost-Vlaanderen, Belgium | Recruiting |
| AZ Groeninge /ID# 268638 | Kortrijk, West-Vlaanderen, Belgium | Recruiting |
| Groupe Sante CHC - Clinique du MontLegia /ID# 268662 | Liège, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06581042